发明名称 EPOTHILONDERIVATE, IHRE SYNTHESE UND VERWENDUNG
摘要 <p>The invention relates to epothilone analog represented by the formula I wherein (i) R 2 is absent or oxygen; "a" can be either a single or double bond; "b" can be either absent or a single bond; and "c" can be either absent or a single bond, with the proviso that if R 2 is oxygen then "b" and "c" are both a single bond and "a" is a single bond; if R 2 is absent then "b" and "c" are absent and "a" is a double bond; and if "a" is a double bond, then R 2 , "b" and "c" are absent; R 3 is a radical selected from the group consisting of hydrogen; lower alkyl; -CH=CH 2 ; -C‰¡CH; -CH 2 F; -CH 2 CI; -CH 2 -OH; -CH 2 -O-(C 1 -C 6 -alkyl); and -CH 2 -S-(C 1 -C 6 -alkyl); R 4 and R 5 are independently selected from hydrogen, methyl or a protecting group; and R 1 is as defined in the specification, or a salt of a compound of the formula I where a salt-forming group is present. A further aspect of the invention is related to the synthesis of epothilone E. These compounds have inter alia microtubuli depolymerisation inhibiting activity and are e.g. useful against proliferative diseases.</p>
申请公布号 DE69933767(T2) 申请公布日期 2007.09.13
申请号 DE1999633767T 申请日期 1999.06.21
申请人 NOVARTIS AG;THE SCRIPPS RESEARCH INSTITUTE 发明人 NICOLAOU, COSTA;KING, PAUL;FINLAY, RAYMOND;HE, YUN;ROSCHANGAR, FRANK;VOURLOUMIS, DIONISIOS;VALLBERG, HANS;BIGOT, ANTONY
分类号 C07D417/06;A61K31/335;A61K31/34;A61K31/365;A61K31/381;A61K31/4178;A61K31/422;A61K31/425;A61K31/427;A61K31/4427;A61P35/00;A61P35/04;A61P43/00;C07D303/00;C07D313/00;C07D405/06;C07D407/06;C07D409/06;C07D413/06;C07D417/14;C07D493/00;C07D493/04 主分类号 C07D417/06
代理机构 代理人
主权项
地址